- EFPIA welcomes new EC structure, but others fear threat to data disclosure
- US Capitol Capsule: Dems target inversion earnings stripping; will Republicans play?
- New French agency head to prioritise drug safety, access to innovation
- French HM backs low-key choice to head medicines agency
- The EMA at 20: CAT chair on where all the advanced therapies are, and Holoclar, the bright light of stem cell therapy
- INTERVIEW: Clinuvel's Philippe Wolgen on Scenesse and the patient factor
JOB OF THE WEEK Promote your job vacancy